Shanghai Shyndec Pharmaceutical Co., Ltd. (600420)

Overview

Shanghai Shyndec Pharmaceutical Co., Ltd., founded in 1996 and headquartered in Shanghai, China, is a comprehensive entity focusing on the research and development, production, and sales of pharmaceutical products on both domestic and international scales. The company specializes in a broad array of pharmaceutical domains, including intermediates, active pharmaceutical ingredients (APIs), and preparations across different therapeutic areas. Its commitment to healthcare extends beyond human medicine, as it also develops animal vaccines and health products, showcasing its versatility in the pharmaceutical industry.

Products and Services

• Pharmaceutical Intermediates:

  Includes crucial compounds like 7-ACA, 6-APA, and penicillin industrial salt. These intermediates are essential for the production of various API products and pharmaceutical preparations, playing a critical role in the development of anti-infection drugs and other types of medications.

• API Products:

  Comprises a range of anti-infection solutions such as azithromycin, amoxicillin, potassium clavulanate, ceftriaxone sodium, among others. These active pharmaceutical ingredients are foundational in the manufacturing of drugs that combat infections and diseases, underscoring the company's commitment to addressing health challenges worldwide.

• Pharmaceutical Preparations:

  Encompasses a wide variety of drugs targeting different therapeutic areas. This includes:

  • Cardiovascular and Cerebrovascular Drugs: These are essential for treating heart and brain blood vessel conditions, with products like enalapril maleate tablets and nifedipine controlled-release tablets.
  • Anti-Aging Drugs: Formulated to slow down the effects of aging, notable mentions include cefuroxime axetil and cefuroxime sodium.
  • Metabolic and Endocrine Drugs: Covers treatment for metabolic syndromes and hormonal imbalances, exemplified by methylprednisolone sodium succinate injectables.
• Therapeutic Areas:

  Shyndec's product portfolio spans across several therapeutic categories, addressing a multitude of medical conditions. These include systemic anti-infection, heart and brain blood vessels management, anti-tumor, immunomodulators, central nervous system health, hormonal treatments, genitourinary and digestive tract conditions, respiratory system diseases, among others. The diverse dosage forms such as tablets, capsules, powder injections, small volume injections, granules, suspensions, suppositories, and ointments, cater to varying patient needs and preferences.

• Animal Health:

  In addition to human pharmaceuticals, Shanghai Shyndec also offers vaccines and general health products for animals. This extension into veterinary medicine demonstrates the company's broad expertise in healthcare, aiming to improve the well-being of both humans and animals.